Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma

Published:2017-05-19 Issue:S11 Volume:123 Page:2118-2129
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lim Su Yin¹²,Menzies Alexander M.²³⁴,Rizos Helen¹²

Affiliation:

1. Faculty of Medicine and Health Sciences; Macquarie University; Sydney New South Wales Australia

2. Melanoma Institute Australia; Sydney New South Wales Australia

3. Sydney Medical School; University of Sydney; Sydney New South Wales Australia

4. Royal North Shore Hospital; Sydney New South Wales Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference115 articles.

1. Cutaneous melanoma;Thompson;Lancet.,2005

2. Mutations of the BRAF gene in human cancer;Davies;Nature.,2002

3. BRAF and RAS mutations in human lung cancer and melanoma;Brose;Cancer Res.,2002

4. Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with BRAF(V600E)-mutated melanoma [abstract 8502];Chapman;J Clin Oncol.,2012

5. An update on BREAK-3, a phase III, randomized trial: dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM) [abstract 9013];Hauschild;J Clin Oncol.,2013

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01

2. AMBRA1 levels predict resistance to MAPK inhibitors in melanoma;Proceedings of the National Academy of Sciences;2024-06-13

3. A New Approach to Melanoma Treatment: microRNAs;Current Topics in Medicinal Chemistry;2024-06

4. Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1;Oncogene;2024-04-03

5. Integrated proteogenomic characterization of glioblastoma evolution;Cancer Cell;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3